Feasibility of endoscopic submandibular ganglion neurectomy for drooling.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 28304087.
- Also identified by DOI 10.1002/lary.26557.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We performed endoscopic transoral neurectomy of the submandibular and sublingual glands to treat drooling. We bilaterally operated two adult cases with treatment-resistant drooling. In these patients, conventional treatment had failed. Repeated botilinum toxin type A (BOTOX®, Abdi Ibrahim Pharmaceutical Company, Istanbul, Turkey) injections had been effective but were becoming less so. The patients benefited from surgery in that their saliva scores decreased. No issue emerged over 6 months of follow-up. Endoscopic transoral neurectomy of the submandibular and sublingual glands reduces saliva production and allows management of drooling in treatment-resistant patients. Laryngoscope, 127:1604-1607, 2017.
Medical subject headings
- Denervation
- Endoscopy
- Ganglia, Parasympathetic
- Sialorrhea
- Submandibular Gland